WEBINAR: Clinical Trials for Thymic Epithelial Tumors
- This event has passed.
WEBINAR: Clinical Trials for Thymic Epithelial Tumors
May 9 @ 09:00 - 10:00 EDT
In May, Thymic Malignancy Awareness Month, we invite you to a webinar:
Clinical Trials for Thymic Epithelial Tumors
May 9, 2023 at 9:00 – 10:00 AM EDT/15:00 – 16:00 CEST
We will present the following currently ongoing clinical trials for thymic tumors. After the presentations, our presenters will answer the questions from the audience.
PROGRAM:
Moderator: Chul Kim, Georgetown University, Washington, DC, USA
Presenters:
- Meredith McAdams, National Cancer Institute, National Institutes of Health, Bethesda, USA
- (NCT05104736) PT-112 in Subjects with Thymoma and Thymic Carcinoma
- (NCT04417660) Bintrafusp Alfa (M7824) in Subjects with Thymoma and Thymic Carcinoma
- Dwight Owen, Ohio State University – James Comprehensive Cancer Center, Columbus, OH, USA
- (NCT03463460) Pembrolizumab and Sunitinib in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer
- Chris Nabel, Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
- (NCT04262466) Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors
- Annemarie Shepherd, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- (NCT05354570) A Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People With Thymic Cancer That Has Spread to the Lining of the Lungs and Chest
- Q&A
RECORDING OF THE WEBINAR WILL BE AVAILABLE SOON
#TETClinicalTrials
